(thirdQuint)A Study of Equivalence of Generic Ingenol Mebutate Gel 0.

05% and Picato Gel 0.

05% in Subjects With Actinic Keratosis.

 Picato(R) (ingenol mebutate) gel is the first and only ingenol mebutate product approved by the FDA in 2012 for the topical treatment of AK(s) on the face and scalp (0.

015% formulation) and on the trunk and extremities (0.

05% formulation).

 A generic ingenol mebutate gel, 0.

05% has been developed for the topical treatment of clinically typical, visible, and discrete non-hyperkeratotic, non-hypertrophic AK lesions of the trunk or extremities.

.

 A Study of Equivalence of Generic Ingenol Mebutate Gel 0.

05% and Picato Gel 0.

05% in Subjects With Actinic Keratosis@highlight

The objective of this study was to evaluate the safety and therapeutic equivalence of generic ingenol mebutate gel, 0.

05% to Picato gel, 0.

05% and to establish the superiority of the efficacy of these two products over the vehicle gel in the treatment of Actinic Keratosis (AK) on the trunk or extremities.

